s

About Academy  |  About IRBAS  |    Contact Us                                                                   ISSN (Online) : 2308-7056 | ISSN (Print) : 2710-0065

International Review of Basic
and Applied Sciences (IRBAS)

Home     Editorial Board     Current Issue     Archive     Indexing      Call for papers     Authors Guideline      Manuscript Submission      Contact

News & Events

Saturday, December 20, 2025
IRBAS Volume 13, Issue 4 has been published.
  
Saturday, December 20, 2025
IRBAS Volume 14, Issue 1, Quarter I of 2026 will publish in Jan-Mar 2026.
  
Monday, October 16, 2023
IRBAS is now HEC Recognized for the year 2023-2024
  
Saturday, December 03, 2022
IRBAS is now HEC Recognized in Category Y from 1st July 2022 till 30th June 2023.
  
Friday, August 06, 2021
IRBAS is now HEC Recognized in Category Y from 1st July 2021 till 30th June 2022.
  
Thursday, September 10, 2020
IRBAS Published on Quarterly basis from Volume 8.
  
Tuesday, January 17, 2017
Recruitment of Reviewers. Reviewers name and affiliation will be listed on the IRBAS journals webpage.
  

IRBAS Citation Report

  All Since 2026
 Citation  326 21
 h-index 11 01
 i10-index 12 01

Hit Counter

Total 1067403
Today's 50
Yesterday's 1004

 Country Wise Counter

Academy Publication Ethics


IRBAS Paper Details

← Back to Volume 11, October 2023 issue

Title Photodynamic Therapy in the Management of Oral Precancerous Lesions
AuthorsSANA SHAKIL KHAN, AREEBA YOUSAF, AREEBA SOHAIL RIZVI, MARIAM MEHTAB and FAIZAN ABDUL HUSSAIN LAKHDIR
Abstract

Oral precancerous lesions, such as leukoplakia and erythroplakia, represent a significant health concern due to their potential for malignant transformation. This research explores the efficacy of Photodynamic Therapy (PDT) as a non-invasive treatment modality in the management of these lesions. A diverse sample of 100 participants was subjected to standardized PDT protocols, with data collected to assess lesion size reduction, patient-reported outcomes, and recurrence rates during a 2-year follow-up period. The findings reveal a highly statistically significant reduction in lesion size following PDT (average reduction of 70.6%), highlighting its potential to target and eliminate these lesions effectively. Moreover, patients reported significant pain relief and a marked improvement in their quality of life, emphasizing the holistic benefits of PDT. Notably, the low recurrence rate of 8% observed suggests that PDT may inhibit the progression of precancerous lesions to malignancy. These results position PDT as a valuable and patient-centered treatment option for oral precancerous lesions. The observed immediate increase in inflammation levels post-PDT underscores the need for future research to understand the modulation of the tumor microenvironment. In conclusion, this study contributes to the growing body of evidence supporting PDT as a promising approach in the management of oral precancerous lesions, offering both physical and patient-centered benefits while reducing the risk of recurrence.
Keywords: Therapy, Oral, Management, PDT.

Volume 11
Issue October
Pages 36-45
Download Download PDF (185 downloads)
AUN

1702787435

Copyright © www.academyirmbr.com : 2012-25. All Rights Reserved.